Hellinida Thomadaki

1.0k total citations
22 papers, 899 citations indexed

About

Hellinida Thomadaki is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Hellinida Thomadaki has authored 22 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Hellinida Thomadaki's work include Cell death mechanisms and regulation (10 papers), Cancer-related Molecular Pathways (6 papers) and Metal complexes synthesis and properties (3 papers). Hellinida Thomadaki is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Cancer-related Molecular Pathways (6 papers) and Metal complexes synthesis and properties (3 papers). Hellinida Thomadaki collaborates with scholars based in Greece and Serbia. Hellinida Thomadaki's co-authors include Andreas Scorilas, Maroulio Talieri, Nikos Katsaros, Konstantinos V. Floros, Alexandra Karaliota, Eleni Κ. Efthimiadou, Yiannis Sanakis, George Psomas, Catherine P. Raptopoulou and C.M. Tsiapalis and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Cancer Letters.

In The Last Decade

Hellinida Thomadaki

22 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hellinida Thomadaki Greece 17 527 337 133 119 100 22 899
Pierre Bischoff France 19 455 0.9× 336 1.0× 220 1.7× 122 1.0× 44 0.4× 39 1.0k
Marcia Pomplun United States 14 497 0.9× 220 0.7× 82 0.6× 115 1.0× 81 0.8× 18 838
Andrew McGown United Kingdom 11 325 0.6× 228 0.7× 107 0.8× 111 0.9× 56 0.6× 28 661
Paul Fleming United States 12 958 1.8× 455 1.4× 395 3.0× 59 0.5× 85 0.8× 23 1.4k
Hemant Parekh United States 16 430 0.8× 323 1.0× 129 1.0× 91 0.8× 28 0.3× 37 773
Caroline Barette France 16 601 1.1× 148 0.4× 186 1.4× 75 0.6× 40 0.4× 40 952
Jiřina Vávrová Czechia 19 656 1.2× 295 0.9× 120 0.9× 178 1.5× 73 0.7× 98 1.2k
Akinori Morita Japan 20 641 1.2× 250 0.7× 82 0.6× 125 1.1× 26 0.3× 48 928
Manuela Gridling Austria 13 672 1.3× 269 0.8× 126 0.9× 97 0.8× 43 0.4× 17 1.0k
Renaud Prudent France 18 687 1.3× 188 0.6× 186 1.4× 45 0.4× 40 0.4× 37 1.1k

Countries citing papers authored by Hellinida Thomadaki

Since Specialization
Citations

This map shows the geographic impact of Hellinida Thomadaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hellinida Thomadaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hellinida Thomadaki more than expected).

Fields of papers citing papers by Hellinida Thomadaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hellinida Thomadaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hellinida Thomadaki. The network helps show where Hellinida Thomadaki may publish in the future.

Co-authorship network of co-authors of Hellinida Thomadaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hellinida Thomadaki. A scholar is included among the top collaborators of Hellinida Thomadaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hellinida Thomadaki. Hellinida Thomadaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomadaki, Hellinida, Konstantinos V. Floros, Sonja Pavlović, et al.. (2012). Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Clinical Biochemistry. 45(16-17). 1362–1367. 9 indexed citations
2.
Thomadaki, Hellinida & Andreas Scorilas. (2011). BAX (BCL2-associated X protein). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 1 indexed citations
3.
Papageorgiou, Sotirios G., Christos K. Kontos, Vassiliki Pappa, et al.. (2011). The Novel Member of the BCL2 Gene Family, BCL2L12, Is Substantially Elevated in Chronic Lymphocytic Leukemia Patients, Supporting Its Value As a Significant Biomarker. The Oncologist. 16(9). 1280–1291. 35 indexed citations
4.
Thomadaki, Hellinida, et al.. (2010). Synthesis, spectroscopic study and anticancer activity of a water-soluble Nb(V) peroxo complex. Journal of Inorganic Biochemistry. 105(2). 155–163. 19 indexed citations
5.
Thomadaki, Hellinida, Konstantinos V. Floros, & Andreas Scorilas. (2009). Molecular Response of HL‐60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis‐Related Gene Expressions, Including the New Member BCL2L12. Annals of the New York Academy of Sciences. 1171(1). 276–283. 19 indexed citations
6.
Thomadaki, Hellinida & Andreas Scorilas. (2008). Molecular Profile of theBCL2Family of the Apoptosis Related Genes in Breast Cancer Cells after Treatment with Cytotoxic/Cytostatic Drugs. Connective Tissue Research. 49(3-4). 261–264. 33 indexed citations
7.
8.
Thomadaki, Hellinida, et al.. (2007). The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemotherapy and Pharmacology. 61(4). 703–711. 26 indexed citations
9.
Thomadaki, Hellinida, et al.. (2007). The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner. Cancer Chemotherapy and Pharmacology. 61(2). 251–265. 51 indexed citations
10.
Thomadaki, Hellinida & Andreas Scorilas. (2007). Breast Cancer Cells Response to the Antineoplastic Agents Cisplatin, Carboplatin, and Doxorubicin at the mRNA Expression Levels of Distinct Apoptosis‐Related Genes, Including the New Member, BCL2L12. Annals of the New York Academy of Sciences. 1095(1). 35–44. 35 indexed citations
11.
12.
Katsarou, Maria E., Hellinida Thomadaki, Nikos Katsaros, & Andreas Scorilas. (2007). Effect of bleomycin and cisplatin on the expression profile ofSRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells. Biological Chemistry. 388(8). 773–778. 1 indexed citations
13.
Thomadaki, Hellinida, Maroulio Talieri, & Andreas Scorilas. (2006). Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biological Chemistry. 387(8). 1081–6. 33 indexed citations
14.
Efthimiadou, Eleni Κ., Hellinida Thomadaki, Yiannis Sanakis, et al.. (2006). Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine. Journal of Inorganic Biochemistry. 101(1). 64–73. 150 indexed citations
15.
Thomadaki, Hellinida, Maroulio Talieri, & Andreas Scorilas. (2006). Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Letters. 247(1). 48–55. 55 indexed citations
16.
17.
Thomadaki, Hellinida & Andreas Scorilas. (2006). BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer. Critical Reviews in Clinical Laboratory Sciences. 43(1). 1–67. 194 indexed citations
18.
Thomadaki, Hellinida, C.M. Tsiapalis, & Andreas Scorilas. (2005). Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biological Chemistry. 386(5). 471–480. 43 indexed citations
19.
Floros, Konstantinos V., Hellinida Thomadaki, Nikos Katsaros, Maroulio Talieri, & Andreas Scorilas. (2004). mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biological Chemistry. 385(11). 1099–103. 32 indexed citations
20.
Floros, Konstantinos V., et al.. (2003). Cisplatin‐Induced Apoptosis in HL‐60 Human Promyelocytic Leukemia Cells. Annals of the New York Academy of Sciences. 1010(1). 153–158. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Bischoff Breakdown of academic impact, for papers by Marcia Pomplun Breakdown of academic impact, for papers by Andrew McGown Breakdown of academic impact, for papers by Paul Fleming Breakdown of academic impact, for papers by Hemant Parekh Breakdown of academic impact, for papers by Caroline Barette Breakdown of academic impact, for papers by Jiřina Vávrová Breakdown of academic impact, for papers by Akinori Morita Breakdown of academic impact, for papers by Manuela Gridling Breakdown of academic impact, for papers by Renaud Prudent
Rankless by CCL
2026